Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Catala, Albert" or (type any "bookEditor journalEditor issueEditor" and editor="Catala, A...

Add to list
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree S. Sahoo, Victor B. Pastor, Charnise Goodings, Rebecca K. Voss, Emilia J. Kozyra, Amina Szvetnik, Peter Noellke, Michael Dworzak, Jan Stary, Franco Locatelli, et al.

(2021) NATURE MEDICINE. 27(10). p.1806-1817
Add to list
- Journal Article
- A1
- open access
Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Emilia J. Kozyra, Victor B. Pastor, Stylianos Lefkopoulos, Sushree S. Sahoo, Hauke Busch, Rebecca K. Voss, Miriam Erlacher, Dirk Lebrecht, Enikoe A. Szvetnik, Shinsuke Hirabayashi, et al.

(2020) LEUKEMIA. 34(10). p.2673-2687
Add to list
- Journal Article
- A1
- open access
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Daniel B Lipka, Tania Witte, Reka Toth, Jing Yang, Manuel Wiesenfarth, Peter Noellke, Alexandra Fischer, David Brocks, Zuguang Gu, Jeongbin Park, et al.

(2017) NATURE COMMUNICATIONS. 8.
Add to list
Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group

Annamaria M Cseh, Charlotte M Niemeyer, Ayami Yoshimi, Albert Catala, Michael C Frühwald, Henrik Hasle, Mary M van den Heuvel-Eibrink, Melchior Lauten, Barbara De Moerloose (UGent) , Owen P Smith, et al.

(2016) BRITISH JOURNAL OF HAEMATOLOGY. 172(6). p.930-936
Add to list
Impact of somatic mutations on the outcome of children and adolescents with therapy-related myelodysplastic syndrome

Brigitte Strahm, Marcin W Wlodarski, Victor B Pastor, Bart Przychodzien, Albert Catala, Michael Dworzak, Oksana Fabri, Henrik Hasle, Kristian Kallay, Riccardo Masetti, et al.

(2016) BLOOD. 128(22).
Add to list
Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

Marcin W Wlodarski, Shinsuke Hirabayashi, Victor Pastor, Jan Starý, Henrik Hasle, Riccardo Masetti, Michael Dworzak, Markus Schmugge, Marry van den Heuvel-Eibrink, Marek Ussowicz, et al.

(2016) BLOOD. 127(11). p.1387-1397
Add to list
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Charlotte M Niemeyer, Mignon L Loh, Annamaria Cseh, Todd Cooper, Christopher C Dvorak, Rebecca Chan, Blanca Xicoy, Ulrich Germing, Seiji Kojima, Atsushi Manabe, et al.

(2015) HAEMATOLOGICA. 100(1). p.17-22
Add to list
Clonal mutational landscape of childhood myelodysplastic syndromes

Emilia J Kozyra, Shinsuke Hirabayashi, Victor Bengt Pastor Loyola, Bartlomiej Przychodzen, Axel Karow, Albert Catala, Barbara De Moerloose (UGent) , Michael Dworzak, Henrik Hasle, Riccardo Masetti, et al.

(2015) BLOOD. 126(23).
Add to list
Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency

Victor Bengt Pastor Loyola, Shinsuke Hirabayashi, Sandra Pohl, Emilia J Kozyra, Albert Catala, Barbara De Moerloose (UGent) , Marek Dworzak, Henrik Hasle, Riccardo Masetti, Markus Schmugge, et al.

(2015) BLOOD. 126(23).
Add to list
- Conference Paper
- C3
- open access
Reduced intensity conditioning for children with refractory cytopenia of childhood : results of the EWOG-MDS study SCT RX RIC 06

Brigitte Strahm, Peter Bader, Albert Catala, Michael Dworzak, Marry Vandenheuvel, Barbara De Moerloose (UGent) , Markus Schmugge, Owen Smith, Petr Sedlacek, Franco Locatelli, et al.

(2014) Childhood Leukemia, 9th Biennial symposium, Abstracts.

Academic Bibliography

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia

Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group

Impact of somatic mutations on the outcome of children and adolescents with therapy-related myelodysplastic syndrome

Prevalence, clinical characteristics and prognosis of GATA2-related myelodysplastic syndromes (MDS) in children and adolescents

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Clonal mutational landscape of childhood myelodysplastic syndromes

Somatic genetic and epigenetic architecture of myelodysplastic syndromes arising from GATA2 deficiency

Reduced intensity conditioning for children with refractory cytopenia of childhood : results of the EWOG-MDS study SCT RX RIC 06

Contents

Support

Contact